The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion ...

Innovative Industrial's AFFO was stable at $1.88/share, and leverage is still low for a REIT. Click here to read why IIPR ...

Cannabis investors have seen rescheduling euphoria ignite and incinerate capital at least four times since 2018, and a fresh ...

Last December, President Trump signed an executive order calling for the rescheduling of marijuana. The DEA is now ...

The rescheduling of medical cannabis to Schedule III has paradoxically created significant uncertainty for banks serving the industry. The decade-old FinCEN guidance, which enabled cannabis banking, ...

The cannabis industry won't have a direct voice in potentially historic hearings next week. And a final outcome is far from certain.

The move only shifted a certain category of weed.

"The Future of Marijuana Rescheduling Will Ultimately Be Decided by Federal Judges, Not Administrative Witnesses" says Duane ...